The role of dietary ingredients in modifying the progression and development of endometriosis.
EC upgrades approval for J&J’s Rybrevant/chemotherapy combination in NSCLC – Pharmaceutical Technology
Rybrevant with chemotherapy is the first treatment to offer prolonged progression-free survival for EGFR-mutated non-small cell lung cancer (NSCLC) patients for whom prior therapy has